Johnson & Johnson quarterly sales rise 12.6 percent

(Reuters) – Healthcare conglomerate Johnson & Johnson (JNJ.N) on Tuesday posted a 12.6 percent rise in quarterly sales, helped by strong demand for its cancer drugs.

The Johnson and Johnson logo is seen at an office building in Singapore January 17, 2018. REUTERS/Thomas White

Sales in the first quarter jumped to $20.01 billion from $17.77 billion a year earlier.

Net earnings fell to $4.37 billion, or $1.60 per share, from $4.42 billion, or $1.61 per share, a year earlier.

Reporting by Manas Mishra in Bengaluru; Editing by Supriya Kurane

News Reporter
The best platform which covers International News, News Today, World News, Sports News, Travel News, Technology News, Fashion News, business News, News about Bitcoin and Health News.

Leave a Reply